The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor H
Open accessAbstract
Summary: OTHER ARTICLES PUBLISHED IN THIS TRANSLATIONAL MINI-REVIEW SERIES ON COMPLEMENT FACTOR H Structural and functional correlations for factor H. Clin Exp Immunol 2008; 151: doi:10.1111/j.1365-2249.2007.03553.x Therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis. Clin Exp Immunol 2008; 151: doi:10.1111/j.1365-2249.2007.03558.x Renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol 2008; 151: doi:10.1111/j.1365-2249.2007.03574.x Factor H is an abundant plasma glycoprotein that plays a critical role in the regulation of the complement system in plasma and in the protection of host cells and tissues from damage by complement activation. Several recent studies have described the association of genetic variations of the complement factor H gene (CFH) with atypical haemolytic uraemic syndrome (aHUS), age-related macular degeneration (AMD) and membranoproliferative glomerulonephritis (MPGN). This review summarizes our current knowledge of CFH genetics and examines the CFH genotype–phenotype correlations that are helping to understand the molecular basis underlying these renal and ocular pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Multipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,028
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Rivera, A., Fisher, S. A., Fritsche, L. G., Keilhauer, C. N., Lichtner, P., Meitinger, T., & Weber, B. H. F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi353 · Cited by 788
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
Noris, M., & Remuzzi, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100861 · Cited by 635
Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · Nature Genetics · doi:10.1038/ng1873 · Cited by 599
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
The human complement factor H: functional roles, genetic variations and disease associations
RODRIGUEZDECORDOBA, S., ESPARZAGORDILLO, J., GOICOECHEADEJORGE, E., LOPEZTRASCASA, M., & SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.02.005 · Cited by 574
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
Kaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Pickering, M. C., Cook, H. T., Warren, J., Bygrave, A. E., Moss, J., Walport, M. J., & Botto, M. (2002) · Nature Genetics · doi:10.1038/ng912 · Cited by 518
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
Hughes, A. E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., & Chakravarthy, U. (2006) · Nature Genetics · doi:10.1038/ng1890 · Cited by 467
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Self-citationFearon, D. T. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1971 · Cited by 418
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Interaction of C-Reactive Protein Complexes with the Complement System
Kaplan, M. H., & Volanakis, J. E. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.112.6.2135 · Cited by 405
Ram, S., Sharma, A. K., Simpson, S. D., Gulati, S., McQuillen, D. P., Pangburn, M. K., & Rice, P. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.743 · Cited by 398
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update
Appel, G. B., Cook, H. T., Hageman, G., Jennette, J. C., Kashgarian, M., Kirschfink, M., Lambris, J. D., Lanning, L., Lutz, H. U., Meri, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010078 · Cited by 380
Dragon-Durey, M.-A., Frémeaux-Bacchi, V., Loirat, C., Blouin, J., Niaudet, P., Deschenes, G., Coppo, P., Herman Fridman, W., & Weiss, L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115702.28859.a7 · Cited by 355
Li, M., Atmaca-Sonmez, P., Othman, M., Branham, K. E. H., Khanna, R., Wade, M. S., Li, Y., Liang, L., Zareparsi, S., Swaroop, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1871 · Cited by 354 · cited 3×
“AMD [27,56–58], aHUS [37,53–55] and MPGN2 [49,50,52, 103 ] are distinct pathological entities that are all associated with mutations and polymorphisms in the gene (CFH), which support the hypothesis that AP dysregulation is a unifying pathogenic feature of these diverse conditions.”
BackgroundInfluentialKazatchkine, M. D., Fearon, D. T., & Kf, A. (1979) · PubMed · Cited by 350
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
The complete amino acid sequence of human complement factor H
Ripoche, J., Day, A. J., Harris, T. J. R., & Sim, R. B. (1988) · Biochemical Journal · doi:10.1042/bj2490593 · Cited by 348
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
Fremeaux-Bacchi, V, Dragon-Durey, M.-A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E., & Fridman, W. H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019083 · Cited by 339
Zipfel, P. F., Edey, M., Heinen, S., Józsi, M., Richter, H., Misselwitz, J., Hoppe, B., Routledge, D., Strain, L., Hughes, A. E., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030041 · Cited by 325
Richards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A., & Goodship, T. H. J. (2001) · The American Journal of Human Genetics · doi:10.1086/318203 · Cited by 310
Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Pérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
Kazatchkine, M. D., Fearon, D. T., & Austen, K. F. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.1.75 · Cited by 290
CAPRIOLI, J., BETTINAGLIO, P., ZIPFEL, P. F., AMADEI, B., DAINA, E., GAMBA, S., SKERKA, C., MARZILIANO, N., REMUZZI, G., & NORIS, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122297 · Cited by 286
Esparza-Gordillo, J., Jorge, E. G. D., Buil, A., Berges, L. C., López-Trascasa, M., Sánchez-Corral, P., & Córdoba, S. R. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi066 · Cited by 281
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Self-citationMapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1
Kühn, S., Skerka, C., & Zipfel, P. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5663 · Cited by 258
Complement biosynthesis by the human hepatoma-derived cell line HepG2.
Morris, K. M., Aden, D. P., Knowles, B. B., & Colten, H. R. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110687 · Cited by 256
Hageman, G. S., Hancox, L. S., Taiber, A. J., Gehrs, K. M., Anderson, D. H., Johnson, L. V., Radeke, M. J., Kavanagh, D., Richards, A., Atkinson, J., et al. (2006) · Annals of Medicine · doi:10.1080/07853890601097030 · Cited by 246
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein
Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M. J., Lindeman, N., Anderson, D. H., Johnson, P. T., Järvelä, I., Jokiranta, T. S., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3831 · Cited by 246
Identification of complement regulatory domains in human factor H
Gordon, D. L., Kaufman, R. M., Blackmore, T. K., Kwong, J., & Lublin, D. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.348 · Cited by 242
Józsi, M., Strobel, S., Dahse, H.-M., Liu, W.-S., Hoyer, P. F., Oppermann, M., Skerka, C., & Zipfel, P. F. (2007) · Blood · doi:10.1182/blood-2007-02-071472 · Cited by 233
Mullins, R. F., Aptsiauri, N., & Hageman, G. S. (2001) · Eye · doi:10.1038/eye.2001.142 · Cited by 231
Identification of the Second Heparin-Binding Domain in Human Complement Factor H
Blackmore, T. K., Hellwage, J., Sadlon, T. A., Higgs, N., Zipfel, P. F., Ward, H. M., & Gordon, D. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3342 · Cited by 222
Complement and diseases: Defective alternative pathway control results in kidney and eye diseases
Zipfel, P. F., Heinen, S., Józsi, M., & Skerka, C. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.015 · Cited by 218
Sánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., López-Trascasa, M., & de Córdoba, S. R. (2002) · The American Journal of Human Genetics · doi:10.1086/344515 · Cited by 218
Self-citationAbrera-Abeleda, M. A., Nishimura, C., Smith, J. L. H., Sethi, S., McRae, J. L., Murphy, B. F., Silvestri, G., Skerka, C., Józsi, M., Zipfel, P. F., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.038315 · Cited by 216
Høgåsen, K., Jansen, J. H., Mollnes, T. E., Hovdenes, J., & Harboe, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117751 · Cited by 213
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.
Thompson, R. A., & Winterborn, M. H. (1981) · PubMed · Cited by 207
Neumann, H. P. H., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Königsrainer, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.676 · Cited by 206
Zipfel, P. F., Jokiranta, T. S., Hellwage, J., Koistinen, V., & Meri, S. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00015-6 · Cited by 205
Licht, C., Heinen, S., Józsi, M., Löschmann, I., Saunders, R. E., Perkins, S. J., Waldherr, R., Skerka, C., Kirschfink, M., Hoppe, B., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000269 · Cited by 205
Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration
Skerka, C., Lauer, N., Weinberger, A. A. W. A., Keilhauer, C. N., Sühnel, J., Smith, R., Schlötzer–Schrehardt, U., Fritsche, L., Heinen, S., & Hartmann, A. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.012 · Cited by 197
Blackmore, T. K., Sadlon, T. A., Ward, H. M., Lublin, D. M., & Gordon, D. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5422 · Cited by 195
Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Localization of the heparin-binding site on complement factor H.
Pangburn, M. K., Atkinson, M. A., & Meri, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55379-5 · Cited by 190
Clark, S. J., Higman, V. A., Mulloy, B., Perkins, S. J., Lea, S. M., Sim, R. B., & Day, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605083200 · Cited by 185
Structural basis for complement factor H linked age-related macular degeneration
Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrín, D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071069 · Cited by 184
Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.
Jokiranta, T. S., Solomon, A., Pangburn, M. K., Pf, Z., & Meri, S. (1999) · PubMed · Cited by 181
SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.01.003 · Cited by 180
An update on the genetics of age-related macular degeneration
Scholl, H. P. N., Fleckenstein, M., Issa, P. C., Keilhauer, C. N., Holz, F. G., & Weber, B. H. F. (2007) · PubMed · doi:10.5283/epub.35844 · Cited by 179
Chen, M., Forrester, J. V., & Xu, H. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.11.015 · Cited by 175
Nephritogenic λ Light Chain Dimer: A Unique Human Miniautoantibody Against Complement Factor H
Jokiranta, T. S., Solomon, A., Pangburn, M. K., Zipfel, P. F., & Meri, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4590 · Cited by 175
Schreiber, R. D., Pangburn, M. K., Lesavre, P. H., & Müller-Eberhard, H. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3948 · Cited by 174
Fremeaux-Bacchi, V, Kemp, E. J., Goodship, J. A., Dragon-Durey, M.-A., Strain, L., Loirat, C., Deng, H.-W., & Goodship, T. H. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030783 · Cited by 171
H deficiency in two brothers with atypical dense intramembranous deposit disease
Levy, M., Halbwachs–Mecarelli, L., Gubler, M., Kohout, G., Bensenouci, A., Niaudet, P., Hauptmann, G., & Lesavre, P. (1986) · Kidney International · doi:10.1038/ki.1986.278 · Cited by 169
Genetic and environmental factors influencing the human factor�H plasma levels
Esparza-Gordillo, J., Soria, J. M., Buil, A., Almasy, L., Blangero, J., Fontcuberta, J., & Rodr�guez de C�rdoba, S. (2004) · Immunogenetics · doi:10.1007/s00251-004-0660-7 · Cited by 167
Giannakis, E., Jokiranta, T. S., Male, D. A., Ranganathan, S., Ormsby, R. J., Fischetti, V. A., Mold, C., & Gordon, D. L. (2003) · European Journal of Immunology · doi:10.1002/eji.200323541 · Cited by 166
Complement factor H and related proteins: an expanding family of complement-regulatory proteins?
Zipfel, P. F., & Skerka, C. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90155-4 · Cited by 159
Ault, B. H., Schmidt, B. Z., Fowler, N. L., Kashtan, C. E., Ahmed, A. E., Vogt, B. A., & Colten, H. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25168 · Cited by 159
Human genes for three complement components that regulate the activation of C3 are tightly linked.
Rodriguez de Cordoba, S., Lublin, D. M., Rubinstein, P., & Atkinson, J. P. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1189 · Cited by 158
FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function
Zipfel, P. F., & Skerka, C. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01432-7 · Cited by 156
Sjöberg, A. P., Trouw, L. A., Clark, S. J., Sjölander, J., Heinegård, D. K., Sim, R. B., Day, A. J., & Blom, A. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610256200 · Cited by 155
Heinen, S., Sánchez‐Corral, P., Jackson, M. S., Strain, L., Goodship, J. A., Kemp, E. J., Skerka, C., Jokiranta, T. S., Meyers, K. E. C., Wagner, É., et al. (2006) · Human Mutation · doi:10.1002/humu.9408 · Cited by 144
Esparza-Gordillo, J., de Jorge, E. G., Abarrategui-Garrido, C., CARRERAS, L., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.008 · Cited by 131
Schwaeble, W., Zwirner, J., Schulz, T. F., LINKE, R. P., Dierich, M. P., & Weiss, E. H. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171015 · Cited by 130
Herbert, A. P., Deakin, J. A., Schmidt, C. Q., Blaum, B. S., Egan, C. L., Ferreira, V. P., Pangburn, M. K., Lyon, M., Uhrín, D., & Barlow, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609636200 · Cited by 128
Pangburn, M. K., Schreiber, R. D., & Müller‐Eberhard, H. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.4.1930 · Cited by 122
Friese, M. A., Hellwage, J., Jokiranta, T. S., Meri, S., Peter, H. H., Eibel, H., & Zipfel, P. F. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00101-7 · Cited by 111
Prodinger, W. M., Hellwage, J., Spruth, M., Dierich, M. P., & Zipfel, P. F. (1998) · Biochemical Journal · doi:10.1042/bj3310041 · Cited by 100
Jokiranta, T. S., Zipfel, P. F., Hakulinen, J., Kühn, S., Pangburn, M. K., Tamerius, J. D., & Meri, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00905-2 · Cited by 95
Alsenz, J., Schulz, T. F., Lambris, J. D., Sim, R. B., & Dierich, M. P. (1985) · Biochemical Journal · doi:10.1042/bj2320841 · Cited by 87
Mold, C., Kingzette, M., & Gewurz, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.2.882 · Cited by 85
Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts
Estaller, C., Weiss, E. H., Schwaeble, W., & Dierich, M. P. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210337 · Cited by 84
Human Factor H-related Protein 5 (FHR-5)
McRae, J. L., Cowan, P. J., Power, D. A., Mitchelhill, K. I., Kemp, B. E., Morgan, B. P., & Murphy, B. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007495200 · Cited by 76
The Human Factor H-related Protein 4 (FHR-4)
Skerka, C., Hellwage, J., Weber, W. T., Tilkorn, A., Buck, F., Marti, T., Kampen, E., Beisiegel†, U., & Zipfel, P. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5627 · Cited by 74
A radiation hybrid map of complement factor H and factor H-related genes
Díaz‐Guillén, M. A., de Córdoba, S. R., & Heine‐Suñer, D. (1999) · Immunogenetics · doi:10.1007/s002510050534 · Cited by 67
Misasi, R., Huemer, H. P., Schwaeble, W., Sölder, E., Larcher, C., & Dierich, M. P. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190936 · Cited by 65
Male, D. A., Ormsby, R. J., Ranganathan, S., Giannakis, E., & Gordon, D. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00024-9 · Cited by 62
An integrated map of the human regulator of complement activation (RCA) gene cluster on 1q32
de Córdoba, S. R., Díaz‐Guillén, M. A., & Heine‐Suñer, D. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00100-5 · Cited by 49
Lokki, M., & Koskimies, S. (1991) · Immunogenetics · doi:10.1007/bf00215259 · Cited by 35
Dali, H., Busnel, O., Hoebeke, J., Bi, L., Decker, P., Briand, J., Baudy-Floc’h, M., & Muller, S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.028 · Cited by 26
Hakobyan, S., Harris, C. L., van den Berg, C. W., Pepys, M. B., & Morgan, B. P. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.194 · Cited by 3
Cited by
Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.003 · Cited by 727
Atypical hemolytic uremic syndrome
Loirat, C., & Frémeaux-Bacchi, V. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-60 · Cited by 669
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
on behalf of the French Study Group for aHUS/C3G, Zuber, J., Fakhouri, F., Roumenina, L. T., Loirat, C., & Frémeaux-Bacchi, V. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.214 · Cited by 496
Complement control protein factor H: The good, the bad, and the inadequate
Ferreira, V. P., Pangburn, M. K., & Cortés, C. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.007 · Cited by 420
Gale, D. P., de Jorge, E. G., Cook, H. T., Martinez-Barricarte, R., Hadjisavvas, A., McLean, A. G., Pusey, C. D., Pierides, A., Kyriacou, K., Athanasiou, Y., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60670-8 · Cited by 327
Self-citation
Metadata
- Authors
- De Córdoba, S. R., & De Jorge, E. G.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-07
- Volume
- 151
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W1491837037
- Cited by
- 287
- References
- 97
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.